Meet the parents putting their kids on Ozempic
Key Points:
- Jenna Ceriani’s son was removed from youth football due to his weight, leading the family to seek treatment with GLP-1 drugs, traditionally used for adults, to address his obesity and related health issues.
- GLP-1 medications like Wegovy and Zepbound are increasingly prescribed for children with obesity and metabolic dysfunction to prevent chronic diseases, though pediatric use remains rare and controversial.
- Experts emphasize that these drugs treat medical conditions beyond weight loss, aiming to improve comorbidities such as fatty liver disease and sleep apnea, and to create opportunities for healthier lifestyle habits.
- Critics caution about unknown long-term effects on children's development and mental health, highlighting the need for more research before widespread pediatric use.
- Despite stigma and social backlash, many parents report significant improvements in their children’s health, confidence, and quality of life after starting GLP-1 therapy.